Relating to insurance coverage for prescription insulin drugs

Sponsored by the House Human Resources Committee

Topics:Business & economy Health care Prescription drug prices

Same legislation: HSB 501, SF 2113

Write your legislators about it

Official bill page Lobbyist declarations One-pager to print

Where it is now

Done: IntroducedJanuary 27, 2020
Skipped: SubcommitteeSkipped
Done: House committeeMarch 9, 2020
Done: Passes the HouseMarch 9, 202098–1
Done: Senate committeeJune 5, 2020
Stopped: Passes the SenateDied when the General Assembly ended
Next: To the Governor
Next: Signed into law

Died when the session ended The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?

What’s in it

This bill relates to prescription insulin drugs and coverage by policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs. The bill requires a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses that provides coverage for prescription drugs to cap the total amount of cost-sharing that a covered person is required to pay for a prescription insulin drug to an amount not more than $100 for a 30-day supply of at least one type of rapid-acting prescription insulin drugs, short-acting prescription insulin drugs, intermediate-acting prescription insulin drugs, or long-acting prescription insulin drugs.

Read the full explanation

“Prescription insulin drug” is defined in the bill as a prescription drug that contains insulin, is used to treat diabetes, has been prescribed as medically necessary by a covered person’s health care professional, and is a benefit covered by a covered person’s policy, contract, or plan. The bill defines “cost-sharing” as any coverage limit, copayment, coinsurance, deductible, or other out-of-pocket expense imposed on a covered person. The bill does not prohibit a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses from reducing a covered person’s cost-sharing to less than $100 for a 30-day supply of a prescription insulin drug. The bill applies to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2021, by the third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the coverage requirements of the bill. The commissioner of insurance may adopt rules to administer the requirements of the bill.

Changed since by amendment H-8016; see Amendments.

Full bill text¹

Senate subcommittee

Named March 10, 2020. It hasn’t reported yet.

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Iowa Code it changes

Creates§514C.18A

How the Code works²

Lobbying

11 for · 0 against · 26 undecided · Who →

Family tree

Study bill

HSB 501Cleared committee

88th General Assembly

HF 2138Passed a chamberHouse companion SF 2113Cleared committeeSenate companion

Picked up later

HF 263Passed a chamber89th GA HF 502Cleared committee90th GA HF 694Cleared committee90th GA

Earlier and later bills are matched by wording or an identical title.

Similar bills

HF 405 Relating to insurance coverage for prescription insulin drugs
91st General Assembly · In committee
Nearly identical
HF 658 Relating to insurance coverage for prescription insulin drugs
91st General Assembly · In committee
Nearly identical
SF 2047 Relating to insurance coverage for prescription insulin drugs
91st General Assembly · In committee
Nearly identical
HF 502 Relating to insurance coverage for prescription insulin drugs
90th General Assembly · In committee
Nearly identical
HF 694 Relating to insurance coverage for prescription insulin drugs
90th General Assembly · In committee
Nearly identical
SF 2062 Relating to insurance coverage for prescription insulin drugs
90th General Assembly · In committee
Nearly identical
SF 2322 Relating to insurance coverage for prescription insulin drugs
91st General Assembly · In committee
Nearly identical
SF 2214 Relating to insurance coverage for prescription insulin drugs
90th General Assembly · Approved by committee
Nearly identical
HF 263 Relating to insurance coverage for prescription insulin drugs, and including applicability…
89th General Assembly · Passed House
Nearly identical
HF 2511 Relating to prescription refills in emergency situations and insurance coverage for prescr…
89th General Assembly · In committee
Similar

Matched by wording or an identical title.